收藏切换
CMC research and evaluation considerations of fatty acid chain-modified glucagon-like peptide 1 drugs
收藏切换
PDF
Jing ZHAO, Wei WEI, Kai-kun WEI
Chinese Journal of New Drugs | 2023, 32(24) : 2507 - 2512
Less
收藏切换
Chinese Journal of New Drugs | 2023, 32(24): 2507-2512
CMC research and evaluation considerations of fatty acid chain-modified glucagon-like peptide 1 drugs
Full
Jing ZHAO, Wei WEI, Kai-kun WEI
Affiliations
  • Center for Drug Evaluation, National Medical Products Administration, Beijing 100076, China
Published: 2023-12-30
Outline
收藏切换

Glucagon like peptide 1 (GLP-1) can inhibit the elevation of glucagon, inhibit gastric acid secretion, and slow down gastrointestinal peristalsis. However, the plasma half-life of GLP-1 is only a few minutes to a few hours. Frequent and high-dose administration are required to achieve therapeutic effects which will increase the risk of adverse effects. Therefore, long acting is an important research interest for GLP-1 drugs. Fatty acid chain modification is the widely used long-acting strategy for GLP-1 drugs due to its advantages of definite modification sites, low heterogeneity of modified products, low loss of biological activity, and low toxic effects. To provide references for the CMC research and evaluation of fatty acid chain-modified GLP-1 drugs and other fatty acid chain-modified peptide drugs, this article shares the experience accumulated in the evaluation of fatty acid chain-modified drugs and proposes the evaluation considerations for recombinant fatty acid chain-modified GLP-1 drugs from the perspectives of raw materials for production, production processes, quality control, and stability research.

fatty acid chain modification  /  glucagon-like peptide 1  /  CMC research  /  long acting  /  evaluation considerations
Jing ZHAO, Wei WEI, Kai-kun WEI. CMC research and evaluation considerations of fatty acid chain-modified glucagon-like peptide 1 drugs[J]. Chinese Journal of New Drugs, 2023 , 32 (24) : 2507 -2512 .
Year 2023 volume 32 Issue 24
PDF
39
12
Cite this Article
BibTeX
Article Info
  • Online Date:2026-03-05
  • Published:2023-12-30
Article Data
Affiliations
History
  • Accepted:2023-11-16
Affiliations
    Center for Drug Evaluation, National Medical Products Administration, Beijing 100076, China
References
Share
https://castjournals.cast.org.cn/joweb/zgxyzz/EN/
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT